Skip to main content
. 2011 Feb 10;4(2):113–116. doi: 10.1093/ndtplus/sfq216

Fig. 1.

Fig. 1.

(A) Plasma oxalate levels during pre-operative HD, intra-operative CVVHDF and post-operative HD in Patient 1. The left and the right vertical dotted line indicates the start and the end of CVVHDF treatment, respectively. (B) Plasma oxalate levels during pre-operative HD, intra-operative CVVHDF and post-operative HD in Patient 2. The left and the right vertical dotted line indicate the start and the end of CVVHDF treatment, respectively.